The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development
15 June 2020
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP’s recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
Further reading: ACS Publications
Author(s): Manica Balasegaram and Laura J. V. Piddock
Smart Innovations
Registration now open:
International Masterclass AMR 29 SEP delivered digitally: 2 = 1!
- Science, Health-Economic & Societal impact
- Global causes and global solutions
- Bottom-up, interactive approach
- International Experts involved
Offered online!
